Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adherence to endocrine therapy including ovarian suppression: A large observational cohort study of US women with early breast cancer

Published:2021-01-28 Issue:8 Volume:127 Page:1220-1227
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Reeder‐Hayes Katherine E.¹²^ORCID,Mayer Sophie E.³,Lund Jennifer L.²³^ORCID

Affiliation:

1. Division of Oncology School of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina

2. Lineberger Comprehensive Cancer Center Chapel Hill North Carolina

3. Department of Epidemiology Gillings School of Public Health University of North Carolina at Chapel Hill Chapel Hill North Carolina

Funder

Conquer Cancer Foundation

Susan G. Komen

Carolina Population Center, University of North Carolina at Chapel Hill

Alliance for Clinical Trials in Oncology Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.33367

Reference21 articles.

1. Use of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trials

2. Ovarian ablation as adjuvant therapy for breast cancer

3. Ovarian ablation as treatment for young women with breast cancer;Davidson NE;J Natl Cancer Inst Monogr,1994

4. Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.

5. Tamoxifen with ovarian function suppression versus tamoxifen alone as an adjuvant treatment for premenopausal breast cancer: a meta-analysis of published randomized controlled trials

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. L’adhésion à l’hormonothérapie adjuvante : un enjeu majeur dans la prise en charge du cancer du sein;Bulletin du Cancer;2024-09

2. Young Age as a Predictor of Chemotherapy Recommendation and Treatment in Breast Cancer: A National Cancer Database Study;Journal of Surgical Research;2024-04

3. Adjuvant Ovarian Function Suppression in Premenopausal Hormone Receptor–Positive Breast Cancer;JAMA Network Open;2024-03-13

4. Borderline indications for ovarian suppression: addressing uncertainties with patients;Future Oncology;2022-12

5. Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel;The Oncologist;2022-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3